Food News and Research

RSS

International Federation of Red Cross and Red Crescent Societies and Coca-Cola enter global partnership

Coca-Cola Hellenic has welcomed the opportunity to build upon its disaster response programme and community development projects across its 28 countries following the signing of a partnership agreement between the International Federation of Red Cross and Red Crescent Societies (IFRC) and The Coca-Cola Company (TCCC).

25 Jan 2011

Regulatory changes needed to protect public health from exposure to toxicants

Americans are exposed to hundreds, if not thousands, of suspected toxic substances every day, substances that affect the development and function of the brain, immune system, reproductive organs or hormones. Children are the most vulnerable. But no public health law requires product testing of most chemical compounds before they enter the marketplace.

25 Jan 2011

NPMA offers tips to recognize and avoid rodent infestations this winter

With the flu and common colds going around, it's hard enough already to stay healthy during the winter, but a rodent infestation could mean a host of other potential health concerns. Rodents can contaminate food sources with feces that can spread Salmonella and Hantavirus. With rodents invading an estimated 21 million homes every winter, the threat to consumers is very real.

25 Jan 2011

Octapharma supports development of 'Diagnosis and Management of von Willebrand Disease' CE supplement

An unrestricted grant from Octapharma USA supported the development of a Continuing Education (CE) initiative entitled the "The Diagnosis and Management of von Willebrand Disease," a program of the National Home Infusion Association (NHIA).

25 Jan 2011

FDA approves IDE Supplement for third patient allotment in HeartWare Ventricular Assist System ADVANCE trial

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has approved an IDE Supplement that allows HeartWare to enroll a third allotment, of 94 additional patients, in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).

25 Jan 2011

NEPAD, GAIN sign Memorandum of Understanding to reduce malnutrition in Africa

The Global Alliance for Improved Nutrition and the New Partnership for Africa Development today announced the signing of a Memorandum of Understanding to significantly contribute to reducing malnutrition in Africa.

25 Jan 2011

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

A new company has been launched to commercialise an award-winning technology, developed at the University of Strathclyde in Glasgow, for tackling bacterial infection and contamination, including superbugs such as MRSA.

25 Jan 2011

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

25 Jan 2011

FDA approves Matrix's generic Protonix DR Tablets ANDA

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-release (DR) Tablets USP, 20 mg (base) and 40 mg (base), the generic version of Wyeth's Protonix® DR Tablets, a treatment for the irritation of the esophagus caused by gastroesophageal reflux disease (GERD).

25 Jan 2011

FDA grants pre-market clearance for SBi's rHead Extended Stem

Small Bone Innovations, an orthopedics company focused exclusively on serving patients and their physicians with technologies and treatments for joint repair and trauma reconstruction around the small bones & joints of the thumb, fingers, hand, wrist, elbow, toes and foot & ankle announced that it has received 510(k) pre-market clearance notification from the U.S. Food and Drug Administration for the radial Head Extended Stem to be used in the correction of complex elbow instabilities and/or elbow reconstruction.

From Evident Corporation - Life Sciences 24 Jan 2011

Weighty matters

The Dieticians Association of Australia (DAA) has launched the “Healthy Weight Week”. The DAA says that 61 per cent of Australian adults and 25 per cent of Australian children are either overweight or obese. At present there are really no drugs that provide long term weight loss. The only resort is surgery.

24 Jan 2011

USAID Administrator responds to conservative Republicans' call for reducing agency's budget

In an interview with Foreign Policy's blog "The Cable," USAID Administrator Rajiv Shah said a Republican Study Committee (RSC) proposal to trim the U.S. foreign aid budget, in addition to other non-defense programs, could weaken U.S. national security.

24 Jan 2011

Also in Global Health News: Cholera death in DR; TB vaccine study; Rising food prices

"Dominican Republic on Sunday confirmed that a 53-year-old Haitian man has become the country's first death from cholera and announced the immediate start of a broad disease control and monitoring operation" around the eastern town of Higuey where he was being treated and later died, Latin American Herald Tribune reports (1/24).

24 Jan 2011

Furiex's MuDelta for diarrhea-predominant irritable bowel syndrome receives FDA Fast Track designation

Furiex Pharmaceuticals, Inc. today announced that its novel diarrhea-predominant irritable bowel syndrome treatment called MuDelta, now in Phase II clinical trials, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

24 Jan 2011

Biomerix receives CE Mark approval for REVIVE soft tissue repair mesh

Biomerix Corporation announced today that it has received CE Mark approval for its REVIVE™ soft tissue repair mesh allowing for the marketing of REVIVE in all European Union member (EU) states. REVIVE received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2009.

24 Jan 2011

CenterWatch quadruples size of Clinical Trials Listing Service

CenterWatch—a leading publisher of clinical trials information—announced that it has more than quadrupled the size of its Clinical Trials Listing Service™ (CTLS). The service now lists more than 80,000 active clinical trials across a wide range of disease conditions, making it the largest online and dynamic database of global clinical trials involving new drugs and devices regulated by the Food and Drug Administration and the Department of Health and Human Services.

24 Jan 2011

Senesco files SNS01-T IND for treatment of multiple myeloma

Senesco Technologies, Inc. today announced that the Company has filed an Investigational New Drug application with the U.S. Food and Drug Administration for Senesco's lead drug candidate SNS01-T for treatment of multiple myeloma.

24 Jan 2011

FDA accepts Optimer's fidaxomicin NDA for filing

Optimer Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for reducing the risk of recurrence when used for treatment of initial CDI.

24 Jan 2011

KineMed's fibrosis research program featured in Nature Medicine

KineMed Inc.'s fibrosis research program, which aims to advance the discovery and development of drugs to treat this major disease, is featured in the January edition of Nature Medicine.

24 Jan 2011

Raptor completes enrollment in DR Cysteamine Phase 3 clinical trial in cystinosis

Raptor Pharmaceutical Corp., today announced it has completed enrollment in its Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").

24 Jan 2011

Food News and Research

International Federation of Red Cross and Red Crescent Societies and Coca-Cola enter global partnership

Regulatory changes needed to protect public health from exposure to toxicants

NPMA offers tips to recognize and avoid rodent infestations this winter

Octapharma supports development of 'Diagnosis and Management of von Willebrand Disease' CE supplement

FDA approves IDE Supplement for third patient allotment in HeartWare Ventricular Assist System ADVANCE trial

NEPAD, GAIN sign Memorandum of Understanding to reduce malnutrition in Africa

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

SNM commends FDA Advisory Committee recommendation for florbetapir approval

FDA approves Matrix's generic Protonix DR Tablets ANDA

FDA grants pre-market clearance for SBi's rHead Extended Stem

Weighty matters

USAID Administrator responds to conservative Republicans' call for reducing agency's budget

Also in Global Health News: Cholera death in DR; TB vaccine study; Rising food prices

Furiex's MuDelta for diarrhea-predominant irritable bowel syndrome receives FDA Fast Track designation

Biomerix receives CE Mark approval for REVIVE soft tissue repair mesh

CenterWatch quadruples size of Clinical Trials Listing Service

Senesco files SNS01-T IND for treatment of multiple myeloma

FDA accepts Optimer's fidaxomicin NDA for filing

KineMed's fibrosis research program featured in Nature Medicine

Raptor completes enrollment in DR Cysteamine Phase 3 clinical trial in cystinosis

Understanding cultivated meat and its global potential eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News